Stock Ticker

  • Loading stock data...

The Virus Testing Stocks Pullback Opportunity (CODX, FLGT, ALST, LH)

The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine candidate, noting that it registered a 90% efficacy rate with no complications in its phase 3 study involving over 43K patients. Stocks took flight, bonds dropped, and small-caps and cyclicals […]

Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commences COVID-19 Vaccine Trials In Teenagers and Children

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years. According to the trial’s lead researcher already parents have shown interest in enrolling children in the study. Pfizer and BioNTech start testing COVID-19 vaccine in kids The trial’s expansion to […]

Pfizer Inc. (NYSE:PFE) And BioNtech (NASDAQ:BNTX) Partners With Rentschler To Purify mRNA-Based COVID-19 vaccine

Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of their mRNA-based SARS-CoV-2 vaccine, BMNT1762b2. Rentschler to purify Pfizer and BioNtech’s COVID-19 vaccine drug substance The companies are conducting late-stage clinical studies of the vaccine and expect to release data […]

Johnson & Johnson (NYSE:JNJ) Coronavirus Vaccine To Start Late-Stage Trial In September

A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the company said the phase three study will enroll 60,000 candidates aged 18 and above in around 180 locations in the U.S and abroad. Details released by the company indicate that […]

Three Stocks for the Battle Ahead (LLY, RXMD, LH)

Eventually, there will be a vaccine.  But, according to the WHO leadership even yesterday, confidence is waning in a “silver bullet” pharma solution for COVID-19. We may be in “coping” mode for quite some time yet.  For investors, that means an increased focus on testing, PPE, and remote process management.  With that in mind, we […]

Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul

Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock price, but the announcement also yielded some criticism. The U.S-based biotech revealed that the initial results of its coronavirus vaccine were promising. This was enough to encourage positive sentiments regarding […]